An interventional study of Exercise and Cognitive behavioral interventions in Aortic Valve Stenosis, sponsored by Brigham and Women's Hospital. Completed at 3 sites in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2021-07-21.
Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Prevention
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure for older adults with severe symptomatic aortic stenosis who are considered high risk for surgical aortic valve replacement. Despite symptomatic and survival benefits, many patients experience functional decline after TAVR. This pilot study aims to test the feasibility of a home-based exercise intervention targeting endurance, strength, and balance as well as cognitive behavioral intervention to improve physical functioning and disability after TAVR.
We hypothesize that a home-based exercise program with cognitive behavioral intervention is more effective than home-based exercise alone; home-based exercise program with and without cognitive behavioral intervention is more effective than attention control educational intervention in preventing decline in physical function and disability after TAVR.
985 studies on the registry are indexed under Aortic Valve Stenosis; 283 are open to participants now.
This study's enrollment of 64 is below the median of 120 across 525 interventional studies indexed under Aortic Valve Stenosis.
Browse Aortic Valve Stenosis studies →Brigham and Women's Hospital is the lead sponsor of 1,236 studies on the registry; 224 are open to participants now.
Of its 116 completed or terminated interventional studies of FDA-regulated products, 64 (55%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
A physical therapist will make home visits, beginning within 1 week of discharge, to deliver an individualized exercise program and cognitive behavioral interventions.
Behavioral: Exercise · Behavioral: Cognitive behavioral interventions
A physical therapist will make home visits, beginning within 1 week of discharge, to deliver an individualized exercise program, without cognitive behavioral interventions.
Behavioral: Exercise
Participants will receive telephone-based education sessions from a study health professional.
Behavioral: Attention control education program
Exercises will target balance, flexibility, strength, and endurance (source: https://go4life.nia.nih.gov/). Home visits will take place twice a week for week 1 and 2; once a week for week 3 and 4; every other week for week for week 5 through week 8. Participants are instructed to do prescribed exercises for 30 minutes daily. The duration of this intervention is about 40 mins.
The following cognitive-behavioral strategies will be employed: 1) enhance positive beliefs about exercise through discussion of benefits of exercise; 2) discussion of barriers to exercise; 3) individualized goal setting and self-monitoring progress using exercise calendar; 4) develop a detailed exercise plan on how, what, when, and where to conduct exercise; 5) $10 rewards for exercising ≥30 mins per day for ≥5 of 7 days. The duration of this intervention is about 20 mins.
A health care professional will call the participant weekly for a period of 8 weeks to teach general tips about exercise and diet (source: https://go4life.nia.nih.gov/). No recommendations for a specific exercise program will be made, except for walking 30 minutes daily or as tolerated. Each telephone session will cover 4 exercise tips and 4 healthy eating tips. The duration of the intervention is about 30 minutes.
Change in the Late-Life Function and Disability Instrument (LLFDI) Score
The LLFDI is a validated patient-reported outcome questionnaire that measures both functional limitations (inability to perform physical tasks - Activity Limitation Domain score, range: 0-100) and disability (inability to perform major life tasks and social roles - Participation Restriction Domain score, range: 0-100). For both scales, higher values indicate better function (lower limitation or lower disability). Two domain scores are analyzed separately.
Time frame: At baseline and week 8
Change in the Short Physical Performance Battery (SPPB) Summary Score
The summary score is calculated based on chair stands, walking speed, and standing balance (range: 0-12). Higher scores indicate better physical performance.
Time frame: At baseline and week 8
Change in the 2-Minute Walk Distance (Feet)
The 2-minute walk distance measures endurance. A longer distance indicates better endurance.
Time frame: At baseline and week 8
Change in Dominant Hand Grip Strength (kg)
Dominant hand grip strength measures upper extremity strength.
Time frame: At baseline and week 8
Number of Participants Who Experienced Adverse Events
Number of participants who experience any adverse events and serious adverse events
Time frame: At week 8
Change in Mini-Mental State Examination (MMSE) Score
MMSE is an instrument that assesses general cognitive function (range: 0 to 30). Higher scores indicate better cognitive function.
Time frame: At baseline and week 8
Change in New York Heart Association (NYHA) Functional Class
NYHA assesses the extent of physical activity limitation due to heart failure. It ranges from 1 (ordinary physical activity does not cause symptoms) to 4 (symptoms occur at rest).
Time frame: At baseline and week 8
Change in the Self-Efficacy Scale for Exercise (SEE)
The SEE scale measures self-efficacy about exercise (range: 0-90). Higher values indicate higher self efficacy.
Time frame: At baseline and week 8
Change in the Outcome Expectation Scale for Exercise (OEE)
The OEE scale measures outcome expectation about exercise (range: 9-45). Higher scores indicate higher expectation.
Time frame: At baseline and week 8
Adherence to the Home-based Exercise Program
The proportion of days with completed daily task during the entire study period will be measured.
Time frame: At week 8
Between August 2017 and February 2020, 64 patients were enrolled from the Beth Israel Deaconess Medical Center and the Brigham and Women's Hospital in Boston, MA.
| Milestone | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Started | 18 | 17 | 19 |
| Completed | 16 | 13 | 16 |
| Not completed | 2 | 4 | 3 |
| Withdrew: Lost to follow-up | 2 | 2 | 2 |
| Withdrew: Post-randomization exclusion | 0 | 2 | 1 |
The LLFDI is a validated patient-reported outcome questionnaire that measures both functional limitations (inability to perform physical tasks - Activity Limitation Domain score, range: 0-100) and disability (inability to perform major life tasks and social roles - Participation Restriction Domain score, range: 0-100). For both scales, higher values indicate better function (lower limitation or lower disability). Two domain scores are analyzed separately.
| units on a scale | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Activity Limitation Domain - Baseline | 53.2 ± 7.2 | 52.0 ± 8.6 | 52.9 ± 5.9 |
| Activity Limitation Domain - Week 8 | 58.9 ± 9.5 | 43 ± 2.8 | 54.4 ± 6.4 |
| Participation Restriction Domain - Baseline | 48.7 ± 8.1 | 47.2 ± 8.6 | 47.3 ± 5.8 |
| Participation Restriction Domain - Week 8 | 49.1 ± 12.0 | 35.3 ± 1.4 | 47.5 ± 13.7 |
The summary score is calculated based on chair stands, walking speed, and standing balance (range: 0-12). Higher scores indicate better physical performance.
| units on a scale | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Baseline | 5.9 ± 0.7 | 4.5 ± 0.8 | 5.3 ± 0.7 |
| Week 8 | 9.7 ± 0.8 | 9.3 ± 0.9 | 6.5 ± 0.8 |
The 2-minute walk distance measures endurance. A longer distance indicates better endurance.
| feet | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Baseline | 313.9 ± 27.2 | 279.0 ± 31.1 | 244.6 ± 32.8 |
| Week 8 | 333.0 ± 25.4 | 357.4 ± 29.5 | 282.8 ± 29.4 |
Dominant hand grip strength measures upper extremity strength.
| kg | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Baseline | 21.8 ± 2.9 | 23.7 ± 3.4 | 19.5 ± 2.8 |
| Week 8 | 23.0 ± 3.1 | 22.8 ± 3.9 | 24.1 ± 3.5 |
Number of participants who experience any adverse events and serious adverse events
| Participants | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Any adverse event | 12 | 8 | 8 |
| Any serious adverse event | 1 | 2 | 1 |
MMSE is an instrument that assesses general cognitive function (range: 0 to 30). Higher scores indicate better cognitive function.
| units on a scale | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Baseline | 25.8 ± 0.8 | 25.8 ± 0.8 | 25.4 ± 0.8 |
| Week 8 | 26.7 ± 0.9 | 28.4 ± 1.1 | 27.7 ± 0.9 |
NYHA assesses the extent of physical activity limitation due to heart failure. It ranges from 1 (ordinary physical activity does not cause symptoms) to 4 (symptoms occur at rest).
| units on a scale | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Baseline | 2.4 ± 0.2 | 2.6 ± 0.2 | 2.2 ± 0.2 |
| Week 8 | 1.7 ± 0.2 | 1.8 ± 0.2 | 1.6 ± 0.2 |
The SEE scale measures self-efficacy about exercise (range: 0-90). Higher values indicate higher self efficacy.
| units on a scale | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Baseline | 50.5 ± 5.8 | 54.5 ± 6.2 | 53.6 ± 5.7 |
| Week 8 | 66.2 ± 6.9 | 59.6 ± 8.7 | 51.1 ± 6.8 |
The OEE scale measures outcome expectation about exercise (range: 9-45). Higher scores indicate higher expectation.
| units on a scale | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Baseline | 19.0 ± 1.3 | 19.2 ± 1.5 | 18.2 ± 1.4 |
| Week 8 | 16.8 ± 1.5 | 16.6 ± 1.9 | 15.7 ± 1.6 |
The proportion of days with completed daily task during the entire study period will be measured.
Results for this outcome have not been posted.
The disability score measures the count of 22 daily activities and physical tasks that a person cannot perform without another person's help. It ranges from 0 to 22. Higher values indicate severe disability. Its correlation with LLFDI was -0.76 against the Activity Limitation Domain score and -0.65 against the Participation Restriction Domain score.
| units on a scale | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Baseline | 2.8 ± 0.4 | 3.1 ± 0.5 | 3.8 ± 0.5 |
| Week 8 | 2.1 ± 0.4 | 3.4 ± 0.5 | 4.5 ± 0.5 |
Collected over Adverse events were collected during the 8-week intervention period.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Exercise & Cognitive Behavioral Int. | 0/18 (0%) | 1/18 (5.6%) | 12/18 (66.7%) |
| Exercise Alone | 0/15 (0%) | 2/15 (13.3%) | 8/15 (53.3%) |
| Attention Control Education Program | 0/18 (0%) | 1/18 (5.6%) | 8/18 (44.4%) |
| Event | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Chest painCardiac disorders | 0/18 | 1/15 | 0/18 |
| DizzinessNervous system disorders | 0/18 | 1/15 | 0/18 |
| HallucinationPsychiatric disorders | 0/18 | 1/15 | 0/18 |
| DiarrheaGastrointestinal disorders | 1/18 | 0/15 | 0/18 |
| Heart failureCardiac disorders | 0/18 | 0/15 | 1/18 |
| EpistaxisBlood and lymphatic system disorders | 1/18 | 0/15 | 0/18 |
| SeizureNervous system disorders | 0/18 | 0/15 | 1/18 |
| Event | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program |
|---|---|---|---|
| Musculoskeletal painMusculoskeletal and connective tissue disorders | 5/18 | 3/15 | 3/18 |
| Chest painCardiac disorders | 3/18 | 1/15 | 2/18 |
| FatigueGeneral disorders | 3/18 | 1/15 | 2/18 |
| DizzinessNervous system disorders | 2/18 | 2/15 | 1/18 |
| FallInjury, poisoning and procedural complications | 1/18 | 1/15 | 1/18 |
| Elevated blood pressureCardiac disorders | 1/18 | 1/15 | 0/18 |
| Leg swellingCardiac disorders | 1/18 | 1/15 | 0/18 |
| AnginaCardiac disorders | 0/18 | 1/15 | 0/18 |
| HallucinationPsychiatric disorders | 0/18 | 1/15 | 0/18 |
| PalpitationCardiac disorders | 0/18 | 1/15 | 0/18 |
Three patients (exercise alone n=2, attention control education n=1) were disenrolled after randomization because they developed medical complications or were discharged to a rehabilitation facility (exclusion criteria).
| Age, Continuous(years) | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program | Total |
|---|---|---|---|---|
| Mean | 85.1 ± 9.1 | 84.9 ± 5.1 | 82.8 ± 8.0 | 84.2 ± 7.6 |
| Sex: Female, Male(Participants) | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program | Total |
|---|---|---|---|---|
| Female | 9 | 1 | 9 | 19 |
| Male | 9 | 14 | 9 | 32 |
| Race (NIH/OMB)(Participants) | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program | Total |
|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 1 | 1 |
| White | 18 | 15 | 17 | 50 |
| More than one race | 0 | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 |
| Region of Enrollment(participants) | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program | Total |
|---|---|---|---|---|
| United States | 18 | 15 | 18 | 51 |
| New York Heart Association Class 3-4(Participants) | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program | Total |
|---|---|---|---|---|
| Count of participants | 8 | 9 | 6 | 23 |
| Aortic valve area(cm^2) | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program | Total |
|---|---|---|---|---|
| Mean | 0.79 ± 0.21 | 0.80 ± 0.22 | 0.80 ± 0.20 | 0.80 ± 0.20 |
| Left ventricular ejection fraction(%) | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program | Total |
|---|---|---|---|---|
| Mean | 60.6 ± 9.4 | 57.0 ± 8.1 | 56.1 ± 15.6 | 58.0 ± 11.6 |
| Body mass index(kg/m2) | Exercise & Cognitive Behavioral Int. | Exercise Alone | Attention Control Education Program | Total |
|---|---|---|---|---|
| Mean | 27.5 ± 6.4 | 27.9 ± 4.8 | 30.6 ± 6.3 | 28.7 ± 6.0 |
5 further baseline measures are reported on the registry.
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brigham and Women's Hospital